Thompson G K, Chen K W, Fischer A B. "一种的合成方法" [P]. US Patent, US 9709251 B2, 2017-01-03.
Hughes D C, Fischer A B, Thompson G K. "Method for the Synthesis of 1-Ethyl-4-(piperidin-4-ylmethyl)piperazine
775288-25-0
9613AE
C12H25N3" [P]. US Patent, US 10044399 B2, 2022-01-13.
Patel M V, O'Brien P Q, Williams B T. "A Process for Preparing High-Purity 1-Ethyl-4-(piperidin-4-ylmethyl)piperazine
775288-25-0
9613AE
C12H25N3" [P]. US Patent, US 11506685 B2, 2018-03-17.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2024, 2316, 3263-3281.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2025, 2242, 1196-1202.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 1-Ethyl-4-(piperidin-4-ylmethyl)piperazine
775288-25-0
9613AE
C12H25N3 Using HRMS and NMR". Molecules, 2015, 2426, 9911-9928.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2024, 2367, (7), 2695-2701.